ERBB2 and breast cancer: Her2-positive (any HR expression status) BC patients presented the lowest variant rate of panel-gene (7.3%, 10/137), and 11 variants were detected among them, mainly including BRCA2 (45.5%, 5/11) and TP53 (18.2%, 2/11).